Patent Assignment
Reel/Frame 020234/0739
Assignment of Assignor's Interest
Recorded: 2007-12-06
Pages: 3
Assignor
VILKOV, ZALMON
Executed: 1999-08-19
Assignee
PUREPAC PHARMACEUTICAL CO.
200 ELMORA AVENUE, ELIZABETH, NEW JERSEY, 07207
Covered Property
(1)
Pharmaceutical Tablet Formulation Containing Gabapentin with Improved Physical and Chemical Characteristics and Method of Making the Same
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
Feb 15, 2002
From: US ORAL PHARMACEUTICALS PTY LTD; PUREPAC PHARMACEUTICALS CO.; FAULDING PHARMACEUTICALS INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 012631/0017 →
Release of Security Interest
Nov 4, 2005
From: BANK OF AMERICA, N.A.
To: PUREPAC PHARMACEUTICAL CO.
Reel/Frame 016722/0849 →
Security Agreement
Nov 21, 2005
From: PUREPAC PHARMACEUTICAL CO.
To: BANK OF AMERICA, N.A., AS AGENT
Reel/Frame 016800/0368 →
Release of Security Interest
Jun 12, 2006
From: BANK OF AMERICA, N.A.
To: PUREPAC PHARMACEUTICAL CO.
Reel/Frame 017759/0882 →
Grant of Security Interest
Nov 28, 2007
From: ACTAVIS ELIZABETH LLC, A LIMITED LIABILITY COMPANY
To: DEUTSCHE BANK AG, LONDON BRANCH, AS SECURITY AGENT
Reel/Frame 020540/0425 →
Conversion
Feb 4, 2008
From: PUREPAC PHARMACEUTICAL CO.
To: ACTAVIS ELIZABETH LLC
Reel/Frame 020451/0919 →
Release of Security Interest in Intellectual Property
Nov 1, 2012
From: DEUTSCHE BANK AG, LONDON BRANCH
To: ACTAVIS ELIZABETH LLC
Reel/Frame 029229/0936 →